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Abstract
Health Issue: The epidemic of human immunodeficiency virus (HIV) and acquired
immunodeficiency syndrome (AIDS) in developed countries has changed from the early epidemic
that affected primarily men who have sex with men, to one that increasingly affects other groups
such as injecting drug users (IDU) and heterosexuals. As a result, the number and percentage of
women with HIV and AIDS is increasing.
Key Findings: The number of women in Canada living with HIV, including those with AIDS, has
increased over time. An estimated 6,800 women were living with HIV at the end of 1999, an
increase of 48.0 % from the 1996 estimate of 4,600. On an annual basis, women account for a
growing proportion of positive HIV test reports among adults in Canada. This proportion increased
from 10.7% in the period 1985–95 to 25% in 2001. Heterosexual contact is the main risk factor for
HIV infection in women, accounting for 63% of newly diagnosed cases of HIV infection in adult
Canadian women in 2001; the majority of the remainder is due to IDU.
Key Data Gaps and Recommendations: Research is needed to address specific information
gaps regarding risk behaviours, testing patterns and HIV incidence and prevalence in women. This
research needs to include the broader contextual factors that influence women's lives and their
risk of HIV infection. Programmes and prevention efforts must be gender and age-specific and
should target not only individual behaviours, but also the social and cultural context in which these
behaviours occur.
Background
The epidemic of HIV and AIDS in developed countries has
changed from the early epidemic, which affected prima-
rily men who have sex with men, to the current one,
which increasingly affects other groups such as injecting
drug users (IDUs) and heterosexuals. As a result of this
shift, the number and percentage of women with HIV and
AIDS is increasing. In addition, HIV infections in women
have the potential for transmission to their infants.
Although HIV/AIDS affects both men and women,
women are more vulnerable for biological, epidemiologic
and social reasons. The broader situations and social con-
ditions that fuel the HIV epidemic, such as marginaliza-
tion, poverty and particularly gender power inequalities,
increase women's vulnerability to HIV infection.
HIV manifests itself differently among women and men,
especially with regard to early symptoms and later
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persistent gynecological infections may be the first clinical
manifestation of HIV in an infected woman and can occur
early in the course of infection. Common early manifesta-
tions of HIV disease in women are recurrent or persistent
vaginal candidiasis (yeast infections), menstrual changes,
pelvic inflammatory disease, human papillomavirus
infections, cervical abnormalities and cervical cancer[1,2].
The two principal ways that adult women acquire HIV are
through injecting drug use and heterosexual contact with
an HIV-infected partner or a partner who is at risk of HIV
infection. Women who work as commercial sex workers,
those who inject drugs, and partners of IDUs are at
increased risk of acquiring HIV. Heterosexual contact is
the main risk factor for HIV among women worldwide.
As of December 31, 2001, the World Health Organization
(WHO) estimated that there were 17.6 million women
living with HIV, constituting 47.3% of the estimated
number of adults living with HIV infection in the
world[1]. This percentage has risen dramatically from 20
years ago, when the AIDS epidemic was first detected.
There is emerging new evidence of rising HIV infection
rates among women in North America, parts of Europe
and Australia. Unsafe sex and injecting drug use are pro-
pelling these epidemics, which at the same time are shift-
ing towards more vulnerable communities. In many parts
of the world, young disadvantaged women are being
infected with HIV at rates higher than their male
counterparts[1,3].
Recent estimates indicate that the number of women in
Canada living with HIV, including those with AIDS, con-
tinues to grow. By the end of 1999, an estimated 6,800
women were living with HIV, an increase of 48% from the
1996 estimate of 4,600[4]. On an annual basis, women
account for a growing proportion of positive HIV test
reports with known age and sex among adults in Canada.
This proportion increased from 10.7% in the years
between 1985 and 1995, to 22% in 1998 and 25% in
2001[5].
This section reviews surveillance data and other epidemi-
ologic publications to give an overview of HIV and AIDS
in women in Canada. As well, the Canadian situation will
be examined in the context of data from other developed
countries.
Methods
AIDS is a clinical diagnosis made by a physician. Cases are
reported to provincial or territorial officials and then to
the national level at the Centre for Infectious Disease Pre-
vention and Control (CIDPC), Health Canada. HIV infec-
tion is a diagnosis made as a result of a positive laboratory
test in an individual who requests an HIV test or is recom-
mended to have one by his or her health care provider.
The surveillance data presented here are derived from
reported cases of AIDS and positive HIV tests across Can-
ada. The databases MEDLINE, AIDSLINE and EMBASE
were searched from 1996 onwards for relevant studies in
English, and a scan of the WHO and UNAIDS Web sites
was also done to obtain additional information on global
HIV/AIDS cases and trends. In addition to these data-
bases, relevant research studies and conference abstracts
available at CIDPC were reviewed.
Results
Reported AIDS Cases
In Canada, of the 17,810 cumulative AIDS cases in adults
reported to CIDPC up to December 31, 2001, there were
1,403 cases in adult women (7.8%)[5]. The proportion of
women among adult AIDS cases with known age and sex
has increased over time, from 5.6% before 1992 to 8.3%
in 1995, peaking at 15.1% in 2001[5].
Reported Positive HIV Tests
Data from provincial and territorial HIV testing programs
indicate that a total of 5,956 positive HIV tests with
known age and gender were reported in adult women up
to December 31, 2001. The proportion of HIV positive
tests among females has risen over time, from 10.7% in
the years between 1985 and 1995 to nearly 25% between
January 1999 and December 31, 2001. This proportion
varies considerably by age and is highest among adoles-
cents and young adults. The proportion of females among
positive HIV test reports in those aged 15 to 29 years has
steadily increased from 14.6% between 1985 and 1995 to
44.5% in 2001[5]; trends among older women (30 years
and older) show only slight increases over time (Figure 1).
Note that proportions should always be examined in con-
junction with the corresponding absolute numbers (Fig-
ure 5); the annual number of test reports among women
aged 15 to 29 has gradually increased over time, whereas
among men it has decreased.
Since the number of positive HIV tests is not a direct esti-
mate of the annual number of new infections (see "Data
Limitations"), CIDPC uses information from AIDS case
reports, provincial/territorial HIV testing databases, popu-
lation-based surveys, targeted epidemiologic studies and
census data to estimate the true incidence. Since the
1980s, the estimated proportion of new HIV infections
among women has increased. In 1999, of the estimated
4,190 new HIV infections, 920 (21.9%) occurred in
women[4].
Risk Factors
The primary exposure categories for Canadian women are
heterosexual contact and injecting drug use, whichPage 2 of 9
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infections in 2001, an increase from 82.7% in the period
1985–1995. Over time, there has been a slight increase in
the proportion of positive HIV test reports attributed to
heterosexual contact and a decrease in the proportion
attributed to injecting drug use (Figure 2); these trends are
also reflected in the absolute number of cases in the
respective categories (Figure 6). Heterosexual contact is
now the main risk factor for HIV infection in women,
accounting for 63% of newly diagnosed cases of HIV
infection in adult Canadian women in 2001[6].
Heterosexual Contact
In Canadian HIV/AIDS surveillance data, the heterosexual
contact category includes individuals who reported heter-
Proportion of Women among Adult (≥ 15 Years) Positive HIV Test Reports, by Age Group and Year of Test (1985/95–2001)Figur  1
Proportion of Women among Adult (≥ 15 Years) 
Positive HIV Test Reports, by Age Group and Year of 
Test (1985/95–2001) Source: Data from HIV and AIDS in 
Canada, Surveillance Report to December 31, 2001.
Distribution of Exposure Category among Adult (≥ 15 Years) Female Positive HIV Test Reports, by Year of Test, Canada (1985/95–2001)igur  2
Distribution of Exposure Category among Adult (≥ 
15 Years) Female Positive HIV Test Reports, by Year 
of Test, Canada (1985/95–2001) Source: Data from HIV 
and AIDS in Canada, Surveillance Report to December 31, 
2001
Proportion of Women and Men among Positive HIV Test Reports, by Age Group i  2001Figu e 3
Proportion of Women and Men among Positive HIV 
Test Reports, by Age Group in 2001 Source: Data from 
HIV and AIDS in Canada, Surveillance Report to December 
31, 2001.
Proportion of Women among Positive HIV Test Reports, by Ethnic Group, 1998–2001Figure 4
Proportion of Women among Positive HIV Test 
Reports, by Ethnic Group, 1998–2001 Source: Data 
from HIV and AIDS in Canada, Surveillance Report to 
December 31, 2001.Page 3 of 9
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This could be from sexual contact with a person who is
either HIV infected or who is at increased risk of HIV infec-
tion – for example, an IDU, bisexual male or someone
from an HIV-endemic country.
The percentage of women whose HIV status is attributed
to heterosexual exposure has steadily increased, from
46.5% in 1985–1995 to 63.5% in 2001[5]. Of the
reported heterosexual HIV cases, 44% are estimated to be
due to sexual contact with an injecting drug user. Extrapo-
lating to all new infections among women, an estimated
20% are related to heterosexual contact with an IDU part-
ner, as compared with 5% of new infections in men.
Therefore, non-IDU women who are sexual partners of
male IDUs form a significant part of the Canadian HIV
epidemic[7]. Heterosexual transmission of HIV most fre-
quently occurs with repeated sexual contact with an HIV-
infected person or people. However, there are other fac-
tors that might increase a woman's susceptibility to
acquiring HIV infection, such as anal sex, sexually trans-
mitted infections (e.g. gonorrhea, genital herpes,
chlamydia), coexisting genital tract inflammation, ulcers
or abrasion, traumatic sex (for example, vaginal bleeding
during sex), contraceptive practices and sexual intercourse
during menstruation[2,3].
Receptive anal intercourse has long been identified as a
strong predictor of HIV transmission between male sexual
partners. However, this sexual practice is rarely discussed
as a primary factor for heterosexual transmission, despite
studies demonstrating that anal intercourse carries a
higher risk than vaginal intercourse[8].
Limited data suggest that HIV is less common among les-
bians than heterosexual women[9,10].
Injecting Drug Use
In Canada, there has been a steady increase in the propor-
tion of adult AIDS cases attributed to IDUs, from 17.8%
Number of Positive HIV Test Reports among Adult Females and Males(≥ 15 Years), by Age Group and Year of Test, 1985–2001Figur  5
Number of Positive HIV Test Reports among Adult Females and Males(≥ 15 Years), by Age Group and Year of 
Test, 1985–2001 Source: Data from HIV and AIDS in Canada, Surveillance Report to December 31, 2001
Number of Positive HIV Test Reports among Adult Females (≥ 15 Years), by Year of Test and Exposure Category, 1985–2001Figur  6
Number of Positive HIV Test Reports among Adult Females (≥ 15 Years), by Year of Test and Exposure Cate-
gory, 1985–2001 Source: Data from HIV and AIDS in Canada, Surveillance Report to December 31, 2001Page 4 of 9
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Three quarters of new HIV infections among women are
directly or indirectly related to injecting drug use[7]. In
addition to sexual exposure through IDU partners and the
trading of sex for drugs or money, women may be exposed
from their own drug use through the sharing of needles
and other drug paraphernalia such as syringes, cotton
balls and spoons. Of all these, the sharing of needles poses
the greatest risk.
In a study in Ottawa, it was reported that 30% of female
IDUs had shared needles in the previous six months[11].
Some studies have shown that the practice of sharing nee-
dles and other injecting behaviours in women are greatly
affected by relationships with their regular male partners.
Female IDUs are less likely than men to shoot up alone
and are more likely than men to have an IDU sexual part-
ner. Women more often than men reported sharing nee-
dles with their regular partner and being injected by their
partner [12-14].
There have been reports of an elevated incidence of HIV
among female as compared with male IDUs[15,16]. A
recent study in Vancouver estimated the HIV incidence
rate among female IDUs to be about 40% higher than that
among male users[15]. An additional risk among female
IDUs is the trading of unprotected sex for money and
drugs. In the Vancouver injection drug use study, 437 of
1,293 participants were female, of whom 318 (73%) iden-
tified themselves as sex trade workers[16]. This study
found that among IDUs who were sex trade workers in
Vancouver during 1999–2000, the prevalence of HIV was
36.8%, whereas in Montreal in the same year the preva-
lence among IDUs who were sex trade workers was
10.5%[16,17].
Studies reveal that the mechanisms compromising
women's injection and sexual safety are intricately and
intimately connected to life histories characterized by
emotional, sexual and physical abuse. For women, previ-
ous sexual or physical victimization may be a predispos-
ing factor to drug use. It has been found that the
prevalence of drug abuse or dependence was four times as




The proportion of females among positive HIV test
reports varies considerably by age and is highest among
adolescents and young adults. Among positive HIV tests
for all males and females in 2001 in Canada, females in
the 15 to 29 year range accounted for 44.5% of all positive
HIV test reports, an increase from 41% in 2000[5]. The
proportion of adult males among reported HIV test
reports is highest in the older age groups (Figure 3).
The limited data available about this group indicate that
young women are involved in behaviours that put them at
increased risk of contracting HIV infection. In the 1996–
1997 NPHS, 25.6% of female participants in the 15 to 19
age group reported that they had had intercourse by the
age of 15 years, as compared with 20% of males in the
same age group. Among sexually experienced single
respondents, 22% of females aged 15 to 24 reported that
they had had more than one sexual partner in the previous
12 months[18].
Research suggests that many Canadian youth are having
unprotected sexual intercourse. In the 1994–1995 NPHS,
of sexually active individuals aged 15 to 19 years, 51% of
females as compared with 29% of males reported never or
only sometimes using a condom in the previous year.
Among those aged 20 to 24, the corresponding percent-
ages were 53% and 44%. The pregnancy rate in young
women aged 15 to 19 years in Canada in 1997 was 42.7/
1,000 and the abortion rate was 21.5/1,000 women. In
2000, the reported incidence of chlamydia and gonorrhea
in Canada was highest among females aged 15 to 19 years:
1,236 and 96.4 per 100,000 women respectively[18]. In a
study of Montréal street youth it was found that, of the
sexually active participants, almost half the girls (47%)
had been pregnant. It was also found that 41% of girls as
compared with 22% of boys reported having had at least
one sexually transmitted infection[19]. The differing rates
of risky sexual behaviours and, as a result, of sexually
transmitted diseases between young women and men can
be attributed in part to the "power" within intimate
relationships. The power in a relationship affects the
woman's ability to take action to minimize acquiring HIV
infection, such as negotiating condom use or the type of
sexual activity she is involved in.
As a result of the synergy between HIV infection and other
STD infection, the presence of other STDs increases the
efficacy of transmission of HIV and increases the suscepti-
bility to infection[2]. In addition to sexual risk, young
women are at risk through injecting drug use. A 1998
study involving Winnipeg IDUs reported that HIV
prevalence was higher among young women than young
men aged 20 to 24: 12.1% versus 8.3%[20].
Women in Prison
Women in prison are at risk of HIV transmission as a
result of injecting drug use as well as risky sexual behav-
iours. The practice of sharing needles and other injecting
equipment can be exacerbated in prisons and jails because
of the extremely limited availability of sterile injecting
equipment. Two studies carried out in Quebec prisonsPage 5 of 9
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female than male inmates (9.8% versus 3.6% in one study
and 7.6% versus 2.2% in the other) as well as higher rates
among female than male IDUs (16% versus 7.7% and
15.6% versus 8.5%)[21,22]. As well, both studies found
that HIV seropositivity among female inmates was related
to prostitution and contact with an HIV positive partner,
either sexually or through injecting drug use.
It is important to note that the higher rates of HIV infec-
tion among women reported here may include infections
that were acquired before incarceration and not necessar-
ily acquired in prison. The social conditions that put
women at increased risk of incarceration include some of
the factors that put them at increased risk for HIV
infection.
Ethnic Groups
Relatively few HIV/AIDS studies in Canada have
addressed ethnic background. Since the beginning of the
AIDS epidemic in 1982, 85% of all AIDS case reports have
included information on ethnicity[5,23]. Overall, Aborig-
inal and Black people are overrepresented among
reported AIDS cases in Canada. The proportion of women
among cumulative AIDS cases is higher among Aboriginal
than non-Aboriginal cases (23.4% versus 8.0%); of the
reported AIDS cases among Aboriginal women for whom
the exposure was known, in 64.9% the risk factor was
injecting drug use and in 30.9% it was heterosexual
contact[5,24].
Ethnicity data for positive HIV test reports have been
available only since 1998 and only for some provinces
and territories. Approximately half of all HIV-positive test
reports among Aboriginal people (45.6%) and Black
people (50%) are from females as compared with 16% in
the white population[23,24]. (Figure 4).
There are very few data on the prevalence and seroconver-
sion rates of HIV among immigrant women or women
from HIV-endemic countries. In one such study, the HIV
prevalence rates among immigrant women were found to
be slightly higher than the rates among Canadian-born
women and women born in non-endemic countries[25].
Women from endemic countries are identified as being at
increased risk of HIV because of their probable exposure
through heterosexual contact and possible exposure to
contaminated blood and blood products or medical
equipment in the country of origin. In a study involving
women undergoing abortion in Montréal from 1989 to
June 2000, it was found that 85% of observed, positive
test results were from women born in HIV-endemic coun-
tries. The HIV prevalence rate among women born in
Haiti was 1.97% and among those born in HIV-endemic
countries other than Haiti was 0.50%, whereas the rate
among those born in Canada and other non-endemic
countries was 0.06%[26]. In a similar study in 1989–
1999, the risk factors identified for HIV infection included
being Haitian-born, having had sex with a man at risk of
HIV, having received a blood transfusion, and using injec-
tion drugs[27].
Pregnant Women
The rate of HIV infection among pregnant women is of
great concern because of possible transmission to the
unborn child. Over the past decade, the number of infants
born to HIV-infected mothers (i.e. HIV-exposed infants)
has increased from 56 in 1991 to 138 in 2001[5]. Of the
reported total of 1,384 infants who were exposed to HIV
from their mothers between 1984 and 2001, 375 have
been confirmed to be HIV positive, and an additional 56
have indeterminate serostatus and are currently being
monitored (data from the Canadian Pediatric AIDS
Research Group)[5].
In all Canadian provinces, HIV testing of pregnant women
remains the choice of the woman. Guidelines and recom-
mendations have been adopted to encourage the provi-
sion of HIV tests with informed consent as part of the
routine prenatal tests. There is now evidence that mother-
to-child transmission can be greatly reduced by antiretro-
viral treatment[28,29]. The HIV transmission rates to
newborns without treatment is estimated at
approximately 24%. This rate can be reduced by three
quarters or more with treatment[30]. A study looking at
trends of antiretroviral drug use in Canada found that the
perinatal HIV transmission rate was reduced to 4.8% with
zidovudine monotherapy and to 2.5% with combined
therapy[28,29].
The proportion of pregnant women known to be HIV pos-
itive who receive antiretroviral therapy in Canada
increased from 37% in 1994 to 84% in 1998[29]. An anal-
ysis to estimate the number of HIV infections among
infants that could be prevented annually in Canada by an
active antenatal HIV testing program found that an esti-
mated 36 HIV infections (65% reduction) could be
prevented among infants each year in Canada by a pro-
gram of 90% testing compared with no testing[30].
In pediatric centres across Canada where children and
HIV-infected mothers were followed between 1995 and
1997, 19% (n = 259) were Aboriginal women. Despite the
high numbers of Aboriginal women seen at HIV clinics
and pediatric centres, the data show that these women are
as likely to be taking antiretroviral therapy (62%) as
pregnant Black (63%) and Caucasian women (66%).
However, 38% of Aboriginal and 27% of Black women
receive antiretroviral therapy late in their pregnancy (inPage 6 of 9
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of white women[24].
Studies of pregnant women can provide an important
source of information on the prevalence rate of HIV in the
general heterosexual population. Prenatal seroprevalence
studies in Canada report an estimated national rate of HIV
infection among pregnant women of approximately 3 to
4 per 10,000 population[6,28]. Large metropolitan areas
have the highest rates: for example, 4.7 per 10,000 in Van-
couver versus 3.4 in the rest of British Columbia in
1994[6], and 15.3 in Montréal versus 5.2 in the rest of the
province of Quebec in 1990[31]. However, even prov-
inces without large metropolitan areas have significant
rates; for example, 4.1/10,000 in New Brunswick during
1994–1996[32].
HIV Testing
HIV testing patterns within the general population, along
with the profile of the people being tested, are important
for designing and targeting intervention programs as well
as developing a context for HIV/AIDS surveillance data.
There are currently three HIV testing options available in
Canada, depending on the province or territory: anony-
mous, nominal/name based and non-nominal/non-iden-
tifying HIV testing[33]. The availability of multiple testing
options increases the chances of women being tested. Peo-
ple with risk factors for HIV are more likely to have been
tested for HIV than those without such risk factors.
If HIV is diagnosed late (long after infection and close to
the time of AIDS development), then the individual is
unaware of his or her HIV status for a long time and, in
addition, along with his or her sexual and/or IDU contacts
cannot benefit from the new HIV treatment and appropri-
ate counselling to reduce potential risk behaviours. In
Canadian AIDS surveillance data, approximately half of
both males (50%) and females (54%) test late for HIV
(HIV diagnosed less than 12 months before AIDS diagno-
sis). Those who were Canadian born were less likely to test
late (46%) than those born outside Canada (65%). Late
testing was significantly more common in Aboriginal,
Asian and Black communities (75.0%, 68.2% and 68.2%
respectively) than among whites (45.2%). In female AIDS
cases, transmission through heterosexual contact, having
no identified risk and being non-white were predictors of
testing late for HIV infection[34].
International Data
The rest of the developed world is experiencing a similar
trend of increasing HIV infections among women. An
overlap of injecting drug use and heterosexual intercourse
appears to be driving the HIV epidemic among
women[1]. In eastern Europe, however, HIV infections are
predominantly due to injecting drug use[35].
In the United States, 40,585 HIV cases in adult and ado-
lescent females were reported up to June 2001, accounting
for 39% of all adult and adolescent HIV cases[36]. Afri-
can-American women have the highest AIDS rate of any
race or ethnic group of women in the United States, and
they account for 67% of female HIV cases[36,37]. A Los
Angeles study found that these women tended to be
unemployed (88%), single mothers (64%), living on pub-
lic assistance (86%), with annual household incomes of
less than US$10,000 (76%), and with a history of crack
use (50%). Compared with women of other races with
HIV and AIDS, they reported more sexual partners (61%),
more sexually transmitted infections, sought treatment for
their HIV infection later, and were more likely to trade sex
for drugs or money[38].
In the United Kingdom and some parts of Europe and
Australia, the increasing number of HIV infections in
women is mainly due to heterosexual contact in HIV-
endemic countries or with partners from HIV-endemic
countries. Migrants from endemic countries account for
the largest proportion of HIV positive women in these
countries[35,38,39]. In the U.K., more than three quarters
of HIV infections resulting from heterosexual exposure
(9,077 of 11,555) are recorded as having been acquired
abroad, primarily in Africa. With the rise in the number of
those who acquired their HIV infections heterosexually,
there has been an increase in the U.K. in the number of
diagnoses in women. The male-female ratio for all new
infections diagnosed in 1985–1986 was approximately
14:1, whereas in 1998–1999 it was about 2.5:1[38,40].
In a study looking at the ethnic differences among women
infected with HIV in Britain and Ireland, researchers
found that Black women had fewer sexual partners (3)
than their white counterparts (7), and that the main route
of transmission was heterosexual contact for Black
women (93%) and a combination of heterosexual contact
(43%) and injecting drug use (55%) for white women.
They also found that for Black women, the infection was
diagnosed at a much later stage[41]. These findings war-
rant further research into the differences that might exist
between ethnic groups in order to plan appropriate
interventions.
Discussion
Despite their limitations, the available data show an
increase in the proportion of women among adult HIV
test reports over time. This proportion varies with age and
is highest in the 15 to 29 age group among both HIV test
reports and reported AIDS diagnoses in Canada.
This chapter focused on the epidemiologic factors that put
women at increased risk of HIV infection. However, these
factors are interconnected with social factors in women'sPage 7 of 9
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acquiring HIV infection occurs within the context of their
interpersonal relationships. This social context is charac-
terized by the HIV risk behaviours of the community of
people the woman belongs to, the cultural norms that pre-
scribe her behaviour within sexual relationships, and her
personal power within her intimate relationships. These
factors affect the woman's ability to take action to
minimize acquiring HIV infection, such as negotiating
condom use or the type of sexual activity she is involved
in [42-44].
HIV appears to be a particular problem for certain sub-
groups of women: women in prison, Aboriginal women
and Black women. The isolation and marginalization in
these ethnocultural communities because of economic
and social circumstances, language barriers, access to
resources and cultural expectations are likely risk factors
for HIV transmission[43,44].
Data Limitations
Changes in the number of reported HIV positive tests as
well as the proportions and trends reported in this chapter
must be interpreted with caution. Surveillance data from
positive HIV test reports are not direct estimates of the
annual number of new HIV infections. This is because
only a proportion of those newly infected in a given year
are tested for HIV in that same year. Furthermore, not all
new HIV test reports in a given year are due to HIV infec-
tions that occurred in that year, since many individuals
will have been infected several years before their first HIV
positive test[5]. In addition, data on risk behaviours, espe-
cially among young women, are not taken from recent
surveys and may be outdated.
Implications and Recommendations
HIV in women encompasses many facets of women's lives
and behaviours. Reducing the toll of the HIV epidemic
among women will require efforts on several fronts:
• There needs to be more research on risk behaviours and
HIV incidence and prevalence among women, especially
in particular subgroups, such as women in prison, young
women, Aboriginal women and those from endemic
countries. This research needs to include the influence of
the broader contextual factors on women's lives and on
their risk of HIV infection.
• More research on HIV testing behaviours and patterns
among women is needed. This will help the individuals to
receive appropriate counselling and treatment as well as
help public health officials to better interpret surveillance
data.
• Programs and prevention messages need to be tailored
to specific social, cultural and economic contexts that may
make women more vulnerable to HIV infection than men.
• Prevention efforts must be sex- and age-specific and
should target not only individual behaviours but also the
social and cultural context in which these behaviours
occur (for example, increasing individual motivation to
use condoms and reducing contextual barriers to their
use).
• Specific interventions are needed to address the intersec-
tion of injecting drug use and HIV transmission. These
interventions should target both women who inject and
those who do not inject but have sexual partners who do.
For both groups of women, violence, unequal gender
roles and power differentials are important elements that
relate to HIV risk behaviour.
• There needs to be an increased emphasis on appropriate
HIV prevention, counselling and testing as well as treat-
ment services for women.
Note
The views expressed in this report do not necessarily rep-
resent the views of the Canadian Population Health
Initiative, the Canadian Institute for Health Information
or Health Canada.
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